Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Test-Retest Reproducibility of 18F-DCFPyL PET/CT in Metastatic Prostate Cancer
NCT03793543Phase 1Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Mar 2019
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoints: Change in number of metastatic lesions detected on 18F-DCFPyL PET/CT from baseline at 4 weeks and Test the intraobserver agreement as assessed by percentage of scans that are read the same on second read at 3 years. Started Mar 2019; status: completed.
Beyond the preview
Go deeper on NCT03793543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03793543.